政府新闻
德国拜耳在中国开设第一家公司实验室 - 2024年09月29日
German pharmaceutical giant Bayer has inaugurated a life sciences co-creation platform in Shanghai, its fourth Bayer Co.Lab globally and first in China.The Bayer Co.Lab China last Thursday celebrated
特斯拉上海工厂在不到4年的时间里出口了100万辆中国制造的汽车 - 2024年09月29日
US electric vehicle maker Tesla announced on Saturday that it has shipped its 1 millionth made-in-China vehicle from its Shanghai plant. Experts say the milestone reflects China's strong and complete industrial supply chains.
上海发放5亿元消费券 - 2024年09月27日
Foreigners, together with locals, are invited to join a shopping spree or enjoy a treat with family and friends as consumption coupons for leisure activities, dining and tourism will soon be offered to all.
寻找“上海风味”的木兰节 - 2024年09月26日
Shanghai upholds magnolia, the flower that represents the city.
论坛聚焦气候挑战中的韧性社区 - 2024年09月26日
In the wake of two powerful typhoons, experts across various disciplines gathered at the 28th SEA-Hi Forum in Changning District to explore the theme "Building Resilient Communities for a Better Life."
中老工程师学院揭牌 - 2024年09月26日
The Shanghai Institute of Technology and Souphanouvong University launched the Sino-Laos Engineering College on Wednesday to cultivate more local talent to serve the China-Laos Railway.
上海将在黄浦江沿岸建设工业博物馆 - 2024年09月26日
Shanghai is to build an industrial museum at a key heritage site along the Huangpu River, officials have revealed.
住宅综合体项目向文化人才开放 - 2024年09月26日
A ceremony was held at a residential compound, a program that provides 200 apartments of affordable housing for cultural talent, in Shanghai's Minhang district on Tuesday, marking its official opening.
蔚来汽车首席执行官表示，新的Onvo品牌与中国电动汽车初创公司的高端品牌相辅相成 - 2024年09月26日
Nio’s second car brand, Onvo, targets the mainstream mass-market segment, complementing rather than competing with Nio’s main brand, which focuses on the premium end, according to the chief executive officer of the Chinese electric vehicle startup.
君实生物：JS125药物临床试验申请获批准 - 2024年09月26日
Shares of Junshi Biosciences gained after the European Union approved the Chinese drugmaker’s monoclonal antibody cancer treatment, which generates most of the company’s revenue.
